Temporal Profile of Serum Neurofilament Light (NF-L) and Heavy (pNF-H) Level Associations With 6-Month Cognitive Performance in Patients With Moderate-Severe Traumatic Brain Injury.
Erin Trifilio, Sarah Bottari, Leah E McQuillan and 7 others
PMID 38758056WHAT IT FOUND
Elevated serum pNF-H levels measured 16 to 90 days after moderate-to-severe traumatic brain injury predict worse cognitive performance at six months.
This association held even after adjusting for age and education. Acute levels and NF-L were not predictive.
Key findings
01Higher serum pNF-H at 16-90 days post-injury was significantly associated with lower executive cognitive composite scores at six months, controlling for age and education.
02Serum NF-L levels at any time interval were not significantly associated with executive cognitive composite scores after controlling for age and years of education.
03Acute serum neurofilament levels (0-15 days) showed minimal relationship with 6-month cognitive outcomes compared to subacute levels.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The sample size was relatively small, and analytic sub-cohorts varied due to missing blood draws or follow-up data. Participants were selected based on their ability to complete neurocognitive testing, which biases the sample toward those with better outcomes. The cohort was skewed toward younger individuals with more severe injuries due to survivorship bias. Correlational analyses were not corrected for multiple comparisons, increasing the risk of false positives. Diffuse axonal injury was identified via CT, which has low sensitivity for this condition, likely leading to underestimation of injury prevalence. The study did not account for how prior comorbidities like cardiovascular risk or psychiatric disorders might influence neurofilament levels.
Declared interests
One author (KKW) is a shareholder of Gryphon Bio, Inc.
The easy way to misread this
Do not use these biomarkers to guide individual patient care or predict specific cognitive deficits in your clinic. The study is observational, the sample is small and biased toward survivors who could complete testing, and no clinically validated thresholds were established. The associations found are statistical, not diagnostic.